|
GOLT1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.618800E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.974500E-02 |
| Normal-vs-Stage2 |
7.562100E-02 |
| Normal-vs-Stage3 |
5.034900E-04 |
| Normal-vs-Stage4 |
2.715800E-02 |
| Stage1-vs-Stage2 |
3.863800E-01 |
| Stage1-vs-Stage3 |
6.543500E-03 |
| Stage1-vs-Stage4 |
2.340400E-02 |
| Stage2-vs-Stage3 |
1.140590E-01 |
| Stage2-vs-Stage4 |
2.361400E-01 |
| Stage3-vs-Stage4 |
8.764600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.655890E-03 |
| Normal-vs-AfricanAmerican |
2.536300E-03 |
| Normal-vs-Asian |
1.802170E-01 |
| Caucasian-vs-AfricanAmerican |
5.120200E-01 |
| Caucasian-vs-Asian |
3.788200E-01 |
| AfricanAmerican-vs-Asian |
5.112600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.463900E-03 |
| Normal-vs-Female |
5.91639999999449E-05 |
| Male-vs-Female |
1.599780E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.244000E-02 |
| Normal-vs-Extreme_Weight |
4.969800E-02 |
| Normal-vs-Obese |
3.138400E-03 |
| Normal-vs-Extreme_Obese |
8.636200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.630600E-01 |
| Normal_Weight-vs-Obese |
5.628200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.981560E-01 |
| Extreme_Weight-vs-Obese |
1.461400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.760800E-01 |
| Obese-vs-Extreme_Obese |
2.741800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.401660E-04 |
| Normal-vs-Age(41-60Yrs) |
4.18170000000551E-05 |
| Normal-vs-Age(61-80Yrs) |
5.592400E-02 |
| Normal-vs-Age(81-100Yrs) |
4.743200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.844800E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.012090E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.475300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.098380E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.456430E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.248200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.099100E-03 |
| Normal-VS-Type2 PRCC |
3.421900E-02 |
| Normal-VS-KIRP CIMP |
7.419100E-04 |
| Normal-VS-Unclassified PRCC |
4.417100E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.604000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.78499999994963E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
9.304300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.551700E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.830210E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.081920E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.865600E-02 |
| Normal-vs-N1 |
3.370000E-04 |
| Normal-vs-N2 |
1.236600E-01 |
| N0-vs-N1 |
3.002300E-03 |
| N0-vs-N2 |
8.520100E-02 |
| N1-vs-N2 |
9.426800E-01 |
|
|
